Skip to main content

For urgent surgical problems, please contact the nearest hospital emergency department.

Gastrointestinal & Colorectal Cancer Surgery

Typical recovery: Recovery varies widely according to the operation. After an uncomplicated laparoscopic segmental colectomy, hospital stay is commonly several days and progressive return to routine activity occurs over the following weeks. Rectal resection, formation of a stoma, multivisceral surgery or open surgery generally requires a longer recovery. Return of bowel function, nutritional recovery and fatigue may take several weeks or longer. Recovery after gastric, pancreatic, liver or other complex cancer surgery is procedure-specific and often occurs within specialist enhanced-recovery pathways. Long-term follow-up depends on final pathology, stage and any adjuvant treatment.

Key points

  • A biopsy proves the diagnosis, but treatment planning also requires accurate staging.
  • Colonoscopy identifies the tumour and allows biopsy, but CT staging is usually needed before definitive colon-cancer surgery.
  • Rectal cancer requires dedicated pelvic staging, usually with high-quality MRI, because tumour height, mesorectal fascia, sphincter relationship and nodal disease influence treatment.
  • Colon and rectal cancers should not be treated as identical diseases; rectal cancer often requires multimodality treatment before surgery.
  • Oncologic colon resection removes the tumour-bearing bowel segment together with its mesentery and regional lymphatic drainage rather than simply cutting out the visible mass.
  • ASCRS guidance recommends complete mesocolic/mesenteric resection appropriate to the tumour-bearing segment and examination of at least 12 lymph nodes for confident node-negative staging.
  • Routine extended D3 lymphadenectomy beyond the standard oncologic field is not required for every colon cancer.
  • When a colon cancer directly invades an adjacent organ and curative surgery is intended, the involved structures should generally be removed en bloc rather than peeling the tumour away.
  • Laparoscopic colon and rectal cancer surgery is appropriate when oncologic principles can be maintained and the tumour and patient are suitable.
  • Open surgery remains appropriate when tumour extent, previous surgery, emergency presentation or technical factors make it safer.
  • For rectal cancer requiring radical resection, total mesorectal excision is a core oncologic principle.
  • Early selected rectal cancers may be suitable for local excision, but this does not remove regional lymph nodes and final pathology can still mandate radical surgery.
  • Locally advanced rectal cancer often receives neoadjuvant treatment or total neoadjuvant therapy before a decision about surgery.
  • A complete clinical response after neoadjuvant treatment does not automatically mean cure. Watch-and-wait is a structured organ-preservation strategy requiring expert assessment and intensive surveillance.
  • Sphincter preservation is desirable when oncologically and technically safe, but avoiding a permanent stoma should never compromise cancer clearance.
  • A temporary diverting ileostomy may be used to reduce the consequences of a leak after a low pelvic anastomosis; it does not guarantee that leakage cannot occur.
  • Emergency presentation with obstruction or perforation can change the surgical strategy and may require staged surgery or stoma formation.
  • Stage III colon cancer commonly requires postoperative systemic therapy, and selected high-risk stage II cancers may also benefit according to pathological and molecular features.
  • Mismatch-repair or microsatellite-instability testing has implications for prognosis, hereditary-cancer assessment and systemic therapy.
  • Metastatic colorectal cancer is not automatically inoperable. Selected liver or lung metastases can be treated with curative-intent local therapy after specialist multidisciplinary review.
  • Conversely, removing an asymptomatic primary tumour is not automatically beneficial when metastatic disease is clearly incurable; the decision should be integrated with systemic therapy and symptom risk.
  • Locally advanced or recurrent rectal cancers that may require beyond-TME or pelvic exenterative surgery should be discussed in specialist centres.
  • Gastric, oesophageal, pancreatic and liver cancers have distinct staging and treatment pathways; major resections should be planned within appropriate specialist multidisciplinary programmes rather than applying colorectal algorithms to them.
  • For resectable gastric cancer, surgery is integrated with perioperative or adjuvant systemic therapy according to stage, geography and multidisciplinary strategy; D2 lymphadenectomy is a standard oncologic principle in appropriately experienced centres.
  • For pancreatic cancer, resectability must be assessed before surgery; borderline-resectable disease commonly receives systemic therapy first, and pancreatic resection is a specialist operation.
  • Enhanced Recovery After Surgery pathways, nutrition, prehabilitation, venous-thromboembolism prevention and early mobilisation can improve recovery from major gastrointestinal cancer surgery.
  • Final pathology determines pathological stage, margin status, lymph-node burden and the need for additional treatment.
  • Cancer surveillance after curative treatment is planned according to tumour site, pathological stage and systemic-treatment pathway rather than using one follow-up schedule for all gastrointestinal cancers.

Overview

Surgery is a central treatment for many cancers of the colon, rectum and selected parts of the gastrointestinal tract, but the correct operation depends on the organ involved, tumour stage, biology, relationship to nearby structures, presence of metastatic disease and the patient's overall fitness. Cancer surgery is therefore planned after staging rather than from the endoscopy or biopsy result alone. Colon cancer is commonly treated by removing the involved segment of bowel together with its mesentery and regional lymphatic drainage, with the exact operation determined by tumour location. Rectal cancer requires different planning because the tumour lies within the pelvis; pelvic MRI, assessment of the mesorectal fascia and lymph nodes, and decisions about neoadjuvant or total-neoadjuvant treatment may all influence whether surgery is performed immediately or after chemotherapy and/or radiotherapy. When rectal resection is required, total mesorectal excision principles are central to oncologic surgery. Some carefully selected early rectal cancers can be treated by local excision, and selected patients who achieve a complete clinical response after neoadjuvant treatment may enter a structured watch-and-wait programme rather than immediate radical surgery, but this requires specialist surveillance. A temporary or permanent stoma is sometimes necessary depending on tumour location, obstruction, the type and safety of an anastomosis, and whether sphincter preservation is oncologically and technically appropriate. Gastrointestinal cancer surgery also includes gastric, small-bowel, pancreatic, liver and other abdominal malignancies, but these diseases have site-specific treatment pathways and many complex procedures are best managed in specialist multidisciplinary and higher-volume programmes. The role of surgery in metastatic disease is also selective: resection of liver or lung metastases, cytoreductive procedures and other major operations are considered only when disease biology, distribution, technical resectability and the overall treatment sequence make meaningful benefit plausible. The goal is not simply to remove a mass, but to achieve appropriate oncologic clearance while preserving function and integrating surgery with systemic therapy, radiotherapy, endoscopy, pathology, radiology and rehabilitation.

Signs & symptoms

  • Persistent change in bowel habit.
  • Blood in stool or rectal bleeding.
  • Iron-deficiency anaemia without an obvious alternative cause.
  • Unexplained weight loss or loss of appetite.
  • Persistent abdominal pain, bloating or progressive distension.
  • Symptoms of bowel obstruction such as colicky pain, vomiting and inability to pass stool or gas.
  • Persistent tenesmus, urgency or altered stool calibre in some rectal cancers.
  • An abdominal or rectal mass detected on examination or imaging.
  • Persistent vomiting, early satiety or upper abdominal symptoms in some upper gastrointestinal cancers.
  • Jaundice or unexplained biliary obstruction in some pancreatic or periampullary cancers.
  • Many gastrointestinal cancers can initially be asymptomatic and are found through screening, endoscopy or imaging.

How assessment and treatment are planned

  1. 1

    Confirm the histological diagnosis whenever feasible and review the original endoscopy and pathology.

  2. 2

    Establish the exact anatomical site of the primary tumour because colon, rectal, gastric, pancreatic and other GI cancers follow different pathways.

  3. 3

    Perform appropriate staging imaging before definitive surgery, commonly including contrast-enhanced CT of the chest, abdomen and pelvis for colorectal cancer.

  4. 4

    For rectal cancer, obtain high-quality pelvic MRI and determine tumour height, T stage, nodal findings, mesorectal fascia involvement and relationship to the sphincter complex.

  5. 5

    Review the case in an appropriate multidisciplinary team when neoadjuvant treatment, complex anatomy, metastatic disease or specialist surgery is relevant.

  6. 6

    Assess operative fitness, frailty, nutrition, anaemia, cardiopulmonary disease and medications before major surgery.

  7. 7

    Optimise nutrition, smoking, diabetes, anaemia and physical conditioning when time and disease status permit.

  8. 8

    For resectable colon cancer, plan a segmental oncologic colectomy based on tumour location with appropriate mesenteric and lymphatic resection.

  9. 9

    For locally invasive colon cancer treated with curative intent, plan en-bloc resection of directly involved adjacent structures when feasible.

  10. 10

    For rectal cancer, determine whether immediate surgery, neoadjuvant therapy, total neoadjuvant therapy, local excision or a structured organ-preservation pathway is most appropriate.

  11. 11

    When radical rectal resection is required, perform surgery according to total mesorectal excision principles and plan the distal bowel/anorectal reconstruction according to tumour location and sphincter involvement.

  12. 12

    Discuss the possibility of a temporary or permanent stoma before surgery whenever it is a realistic outcome.

  13. 13

    Use laparoscopic or open surgery according to tumour anatomy, previous operations, emergency status and surgeon/institutional expertise while maintaining oncologic principles.

  14. 14

    Send the intact surgical specimen for detailed pathological assessment including margins, tumour stage and lymph-node evaluation.

  15. 15

    Review final pathology in the multidisciplinary setting and determine whether adjuvant chemotherapy, radiotherapy or additional surgery is indicated.

  16. 16

    For metastatic colorectal cancer, assess whether metastases are resectable or ablatable and coordinate the sequence of systemic and local treatment.

  17. 17

    Refer patients needing highly specialised oesophageal, pancreatic, liver, cytoreductive/HIPEC or pelvic exenterative procedures to the appropriate specialist multidisciplinary programme.

  18. 18

    Arrange site- and stage-specific surveillance after completion of curative-intent treatment.

Preparation

  • Bring colonoscopy, upper-GI endoscopy or other endoscopic reports and biopsy results.
  • Bring CT, MRI, PET or other staging images and reports rather than only the written summary when possible.
  • For rectal cancer, bring the dedicated pelvic MRI and multidisciplinary treatment recommendation.
  • Bring previous operative notes if you have had abdominal or pelvic surgery.
  • Tell the surgeon about previous chemotherapy, radiotherapy or immunotherapy and the dates completed.
  • Bring a current medication list, particularly anticoagulants and antiplatelet medicines.
  • Do not stop blood-thinning medication without a specific perioperative plan.
  • Discuss weight loss, appetite, nutritional supplements and any difficulty eating because preoperative nutrition can affect recovery.
  • Tell the team about heart, lung, kidney disease, diabetes, smoking and previous anaesthetic problems.
  • Ask whether bowel preparation and oral antibiotics are required for the planned colorectal procedure; protocols vary by operation and institution.
  • If a stoma is possible, request preoperative stoma counselling and site marking when feasible.
  • Ask how the proposed operation fits into the overall cancer plan, including whether chemotherapy or radiotherapy is needed before or after surgery.

Recovery and aftercare

  • Follow the enhanced-recovery plan for mobilisation, breathing exercises, oral intake and pain control when one is used.
  • Attend postoperative review for final histopathology and pathological staging.
  • Seek urgent review for increasing abdominal pain, persistent vomiting, fever, rapid heart rate, wound infection or inability to tolerate fluids after discharge.
  • If you have a stoma, follow stoma-care teaching and contact the stoma team early for leakage, skin problems or output concerns.
  • After colorectal resection, bowel frequency and consistency may change for weeks or months and depend on how much bowel or rectum was removed.
  • After low rectal surgery, discuss symptoms of low anterior resection syndrome if frequency, urgency, clustering or incontinence persists.
  • Resume nutrition progressively and use dietetic support when weight loss or reduced intake is significant.
  • Do not delay prescribed adjuvant oncology review while waiting for complete return to preoperative fitness.
  • Follow the surveillance schedule recommended for the specific tumour site and pathological stage.
  • Report new bleeding, persistent change in bowel habit, unexplained weight loss or new abdominal symptoms during surveillance rather than waiting for the next routine appointment.
  • Maintain physical activity, smoking cessation and general health optimisation as recovery allows.

Risks and possible complications

  • Bleeding and need for transfusion.
  • Wound infection.
  • Intra-abdominal or pelvic abscess.
  • Anastomotic leak, which can require drainage, reoperation or stoma formation.
  • Postoperative ileus or bowel obstruction.
  • Venous thromboembolism.
  • Chest infection and other cardiopulmonary complications.
  • Urinary dysfunction after pelvic surgery.
  • Sexual dysfunction after rectal or pelvic cancer surgery.
  • Temporary or permanent stoma formation.
  • Low anterior resection syndrome after sphincter-preserving rectal surgery.
  • Incisional or parastomal hernia.
  • Injury to nearby structures such as ureter, bladder, spleen or small bowel depending on the operation.
  • Need for multivisceral resection in locally advanced disease.
  • Positive surgical margins or residual cancer when complete resection is not technically achievable.
  • Cancer recurrence locally or at distant sites.
  • Nutritional problems after gastric, pancreatic or extensive bowel resection.
  • Delayed recovery that postpones planned systemic anticancer treatment.

When to seek medical care

  • SOON: Persistent rectal bleeding or blood mixed with stool.
  • SOON: Unexplained iron-deficiency anaemia.
  • SOON: Persistent change in bowel habit lasting several weeks.
  • SOON: Unexplained weight loss, reduced appetite or progressive fatigue.
  • SOON: Persistent abdominal or rectal pain associated with altered bowel function.
  • SOON: A known gastrointestinal cancer that has not yet undergone complete staging or multidisciplinary treatment planning.
  • SOON: New symptoms or rising tumour markers after previous colorectal or gastrointestinal cancer treatment.
  • URGENT: Increasing abdominal distension, repeated vomiting and inability to pass stool or gas suggesting bowel obstruction.
  • URGENT: Severe abdominal pain with guarding, rigidity or free perforation concern.
  • URGENT: Heavy ongoing gastrointestinal bleeding with dizziness, faintness or haemodynamic instability.
  • URGENT: Fever, severe abdominal pain or systemic illness after recent bowel surgery.
  • URGENT: Progressive jaundice with fever or sepsis symptoms in a patient with biliary obstruction.
  • EMERGENCY: Collapse, shock, peritonitis or suspected anastomotic leak after gastrointestinal cancer surgery.

Myth vs fact

Frequently asked questions

Sources

Medically reviewed by Dr. Shams Alam Mohammed Tahir, MBBS, MS (General Surgery). Last reviewed 2026-09-20.

WhatsApp